Log in or Sign up for Free to view tailored content for your specialty!
Alzheimer's Disease/Cognition News
Q&A: New Alzheimer’s dataset allows ‘whispers from the brain’ to assist in early detection
The future of Alzheimer’s disease detection and treatment may lie in AI-based datasets encompassing an abundance of real-world evidence from a large number of patients, an expert said.
Hypothyroidism does not worsen rate of cognitive decline for perimenopausal women
Women with hypothyroidism receiving levothyroxine treatment experienced similar cognitive decline during menopause as those without thyroid disease, according to data published in Thyroid.
Log in or Sign up for Free to view tailored content for your specialty!
Tea, red wine among foods tied to lower risk for dementia
Adults who more frequently consumed several flavonoid-rich foods, like berries and tea, had a significantly lower risk for dementia, according to an analysis published in JAMA Network Open.
Gender, sexual identity may be associated with brain health outcomes
LGBTQ+ people may be more likely to experience adverse brain health outcomes, including late-life depression and dementia, compared with cisgender straight people, according to study results published in Neurology.
Diagnostic firm receives $7 million to advance novel Alzheimer’s biomarker platform
C2N Diagnostics has been awarded more than $7 million from the Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator initiative to advance a novel platform intended to boost Alzheimer’s disease biomarker detection.
Gut microbiota in older cancer survivors linked to cognitive function
ORLANDO, Fla. — An analysis of the gut microbiome among individuals who survived cancer revealed a significant association between the gut-brain axis, particularly in gut microbiota, metabolism and cognitive function, according to a poster.
MIND diet may reduce the risk for cognitive decline
Higher adherence to the Mediterranean-DASH Intervention for Neurodegenerative Delay, or MIND) diet reduced the risk for cognitive impairment, particularly in women, results from a cohort study published in Neurology showed.
VIDEO: More data support first FDA-approved drug to treat Alzheimer’s-related agitation
PHILADELPHIA — In this Healio Video Perspective from the Alzheimer’s Association International Conference, Johan Luthman, PhD, discusses new data from post hoc analyses evaluating the efficacy of Rexulti for Alzheimer’s-related agitation.
One in three former professional football players believe they have CTE
Around one-third of former professional football players perceived themselves as having chronic traumatic encephalopathy, according to results from a cross-sectional study published in JAMA Neurology.
Diabetes drug linked to reduced risk for dementia, Parkinson’s disease
The use of sodium-glucose cotransporter 2 inhibitors reduced the risk for multiple neurodegenerative diseases in adults with type 2 diabetes, according to study results published in Neurology.
-
Headline News
‘Having women at the top’ drives structural change, advances gender equity in GI
January 13, 202510 min read -
Headline News
Do I really have to go to the hospital for my mini stroke?
January 09, 20257 min read -
Headline News
Survey shows radiation oncology in ‘dark place’ as prior authorization burden worsens
January 14, 20255 min read
-
Headline News
‘Having women at the top’ drives structural change, advances gender equity in GI
January 13, 202510 min read -
Headline News
Do I really have to go to the hospital for my mini stroke?
January 09, 20257 min read -
Headline News
Survey shows radiation oncology in ‘dark place’ as prior authorization burden worsens
January 14, 20255 min read